The sodium glucose cotransporter 2 (SGLT-2) inhibitor drug dapagliflozin, widely used to treat type 2 diabetes, also shows ...

Almost exactly a year after launching its Obesity Association, the American Diabetes Association (ADA) has recruited Novo ...

Eli Lilly joins up with Camurus to make long-acting versions of the pharma's obesity and diabetes drugs, joining the industry ...

This review examines dietary interventions that can improve cardiometabolic health, highlighting the role of whole foods in ...

Researchers are beginning to wonder if blockbuster drugs like Wegovy, Ozempic and Zepbound could play a role in preventing ...

Enrollment in a patient-delivered intervention allowed adults with overweight or obesity to better maintain weight loss than ...

Recent data from National Health Service (NHS) weight clinics in England show that a disproportionate number of referrals originate from the most deprived areas, with some children having BMIs over 40 ...

Artificial intelligence (AI) is transforming dietary management for diabetes and obesity, offering personalized nutrition ...

That overweight person you’re judging might not be able to control the amount they eat. For ten years, Joshua Bell was part ...

GLP-1 receptor agonists may modestly reduce the risk for 14 obesity-related cancers, especially colorectal cancer, among ...